Inhibitory effect of erythromycin P-glycoprotein-mediated biliary excretion of doxorubicin in rats

Anticancer Research

Volumn 20, Issue 5, 2000, Pages 2827-2834

  Kiso, S I ^a   Shao Hui Cai, ^a   Kitaichi, K ^a   Furui, N ^a   Takagi, K ^a   Nabeshima, T ^a   Hasegawa, T ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Anticancer drug resistant cells; Biliary and renal excretion; Doxorubicin; Erythromycin; P glycoprotein; P388 ADR cells

Indexed keywords

DOXORUBICIN; ERYTHROMYCIN; ERYTHROMYCIN LACTOBIONATE; GLYCOPROTEIN P;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG INFUSION; DRUG INHIBITION; DRUG TRANSPORT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BILIARY TRACT; DISACCHARIDES; DOXORUBICIN; ERYTHROMYCIN; INTRACELLULAR FLUID; KIDNEY; MALE; MICE; P-GLYCOPROTEIN; RATS; RATS, WISTAR; TUMOR CELLS, CULTURED;

EID: 0033785929     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
2. The human multidrug resistance (mdr 1) gene. cDNA cloning and transcription initiation
3. Increased accumulation of vincristine and adriamycin in drug-resistant tumor cells following incubation with calcium antagonists and calmodulin inhibitors
4. Mechanisms of multidrug resistance and implications for therapy
5. The biochemistry of P-glycoprotein-mediated multidrug resistance
6. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein
7. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
8. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
9. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats
10. Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level
11. Biliary disposition of adriamycin
12. Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats
13. Effect of the nonimmunosuppressive cyclosporin analog SDZ PSC-833 on colchicine and doxorubicin biliary secretion by the rat in vivo
14. Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833
15. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
16. Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line
17. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog
18. Cyclosporins as drug resistance modifiers
19. Effect of stauosporine derivatives on protein kinase activity and vinblastine accumulation in mouse leukemia P388/ADR cells
20. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo
21. Antitumour effects and pharmacokinetics of combination of vinblastine with a staurosporine derivative, NA-382, in P388/ADR-bearing mice
22. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo
23. Reversal of multidrug resistance by an immunosuppressive agent FK-506
24. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells
25. Effect of clarithromycin on renal excretion of digoxin: Interaction with P-glycoprotein
26. Transport of rhodamine 123, a P-glycoprotein substrate, across intestine and Caco-2 cell monolayers in the presence of cytochrome P450 3A-related compounds
27. Effects of phenobarbitone on the distribution, metabolism and biliary excretion of erythromycin in rats
28. Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia
29. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
30. Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo
31. Effect of cyclosporine on colchicine partitioning in the rat liver
32. Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: Role of canalicular multispecific organic anion transporter and P-glycoprotein
33. Pharmacokinetic modulation of irinotecan and metabolites by cyclosporin A
34. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes
35. Hepatobiliary secretion of organic compounds: Molecular mechanisms of membrane transport
36. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
37. Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline
38. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS)